CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-01 | Mokari Atabak Chief Financial Officer | Grant or award | +1,651 | $22.97 | $38K | 5,757 |
| 2023-06-01 | Mokari Atabak Chief Financial Officer | Grant or award | +1,651 | 7,408 | ||
| 2023-06-01 | Maduck Sean See Remarks | Grant or award | +1,658 | $22.97 | $38K | 61,040 |
| 2023-06-01 | Maduck Sean See Remarks | Grant or award | +1,658 | 62,698 | ||
| 2023-05-19 | BAKER G LEONARD JR Director | Grant or award · Stock Option (Right To Buy) | +30,000 | 30,000 | ||
| 2023-05-19 | Alton Gregg H Director | Grant or award · Stock option (right to buy) | +30,000 | 30,000 | ||
| 2023-05-19 | WILSON JAMES N Director | Grant or award · Stock option (right to buy) | +80,000 | 80,000 | ||
| 2023-05-19 | Cannon Gillian Director | Grant or award · Stock option (right to buy) | +30,000 | 30,000 | ||
| 2023-05-19 | Park Kimberly Director | Grant or award · Stock option (right to buy) | +30,000 | 30,000 | ||
| 2023-05-19 | Swisher Daniel N JR Director | Grant or award · Stock option (right to buy) | +30,000 | 30,000 | ||
| 2023-05-19 | MAHONEY DAVID L Director | Grant or award · Stock option (right to buy) | +30,000 | 30,000 | ||
| 2023-05-19 | Murray Joshua M. Director | Grant or award · Stock option (right to buy) | +30,000 | 30,000 | ||
| 2023-05-10 | Robb Gary Charles Chief Business Officer | Sale | −14,000 | $24.07 | $337K | 19,997 |
| 2023-05-09 | Robb Gary Charles Chief Business Officer | Sale | −30,000 | $23.87 | $716K | 33,997 |
| 2023-05-08 | MAHONEY DAVID L Director | Option exercise | +30,000 | $1.74 | $52K | 1,239,275 |
| 2023-05-08 | MAHONEY DAVID L Director | Shares withheld for taxes | −2,197 | $23.76 | $52K | 1,237,078 |
| 2023-05-08 | MAHONEY DAVID L Director | Option exercise · Stock option (right to buy) | −30,000 | 0 | ||
| 2023-05-05 | Robb Gary Charles Chief Business Officer | Option exercise | +45,000 | $1.92 | $86K | 64,583 |
| 2023-05-05 | Robb Gary Charles Chief Business Officer | Option exercise | +60,000 | $3.29 | $197K | 124,583 |
| 2023-05-05 | Robb Gary Charles Chief Business Officer | Shares withheld for taxes | −60,586 | $24.07 | $1.5M | 63,997 |
Page 51 of 61 · 1,220 trades